If you or someone in your family has experienced a serious side effect to a health product, you are encouraged to report the experience to your health care professional (e.g. physician, pharmacist). You could also complete a copy of the side effect reporting form or report your side effect to FDA.

Dacarbazine Side Effects Reported to FDA

This is a report of a 56-year-old male patient (weight: NA) from US, suffering from the following health symptoms/conditions: hodgkin^s disease, who was treated with Dacarbazine (dosage: NA, start time:

Oct 04, 2013), combined with: NA. and developed a serious reaction and side effect(s): Chills, Pyrexia, Tachycardia, Wheezing, Investigation after the beginning of treatment. This case can indicate the possible existence of increased vulnerability to Dacarbazine treatment in male patients, resulting in Chills side effect.

Dacarbazine Side Effect Report#9885310 Myelodysplastic Syndrome

This report suggests a potential DacarbazineMyelodysplastic Syndrome side effect(s) that can have serious consequences. A 44-year-old male patient (weight: NA) from JP was diagnosed with the following symptoms/conditions: malignant melanoma and used Dacarbazine (dosage: 5000 Mg) starting NS. After starting Dacarbazine the patient began experiencing various side effects, including: Myelodysplastic SyndromeAdditional drugs used concurrently: NA. Although Dacarbazine demonstrated significant improvements in a number of clinically relevant cases, troublesome symptoms, such as Myelodysplastic Syndrome, may still occur.

This Clostridium Difficile Infection problem was reported by a physician from US. A 43-year-old male patient (weight: NA) was diagnosed with the following symptoms/conditions: hodgkin^s disease. On NS this consumer started treatment with Dacarbazine (dosage: NA). The following drugs were being taken at the same time:

Doxorubicin

Vinblastine

Bleomycin

Oxycodone W/paracetamol

When using Dacarbazine, the patient experienced the following unwanted symptoms/side effects: Clostridium Difficile Infection, Clostridium Difficile Colitis, PancytopeniaThe patient was hospitalized.Although all drugs are carefully tested before they are licensed for use, they carry side effect risks. Some side effects, such as Clostridium Difficile Infection, may become evident only after a product is in use by the general population.

This Abscess side effect was reported by a physician from GB. A 47-year-old male patient (weight:NA) experienced the following symptoms/conditions: malignant melanoma.The patient was prescribed Dacarbazine (drug dosage: NA), which was initiated on

This is a report of a 84-year-old male patient (weight: NA) from US, suffering from the following health symptoms/conditions: malignant melanoma, who was treated with Dacarbazine (dosage: 1820mg Cyclical, start time:

Aug 26, 2013), combined with: NA. and developed a serious reaction and side effect(s): Hypoglycaemia, Fatigue, Chills, Hypotension after the beginning of treatment. This case can indicate the possible existence of increased vulnerability to Dacarbazine treatment in male patients, resulting in Hypoglycaemia side effect.

Dacarbazine Side Effect Report#9531313 Thrombocytopenia

This report suggests a potential DacarbazineThrombocytopenia side effect(s) that can have serious consequences. A 34-year-old male patient (weight: NA) from US was diagnosed with the following symptoms/conditions: metastatic malignant melanoma and used Dacarbazine (dosage: 1 Cycle) starting NS. After starting Dacarbazine the patient began experiencing various side effects, including: ThrombocytopeniaAdditional drugs used concurrently: NA. Although Dacarbazine demonstrated significant improvements in a number of clinically relevant cases, troublesome symptoms, such as Thrombocytopenia, may still occur.

This Alanine Aminotransferase Increased problem was reported by a consumer or non-health professional from US. A 55-year-old male patient (weight: NA) was diagnosed with the following symptoms/conditions: metastatic malignant melanoma. On

May 31, 2013 this consumer started treatment with Dacarbazine (dosage: 1539 Mg, Unk). The following drugs were being taken at the same time:

Monoclonal Antibodies (680 Mg, Unk)

Zolpidem (Unk)

Palonosetron (Unk)

Hydroxyzine Hcl (Unk)

Aprepitant (Unk)

Difluprednate

Loxoprofen (Unk)

Rebamipide (Unk)

When using Dacarbazine, the patient experienced the following unwanted symptoms/side effects: Alanine Aminotransferase Increased, Aspartate Aminotransferase IncreasedThe patient was hospitalized.Although all drugs are carefully tested before they are licensed for use, they carry side effect risks. Some side effects, such as Alanine Aminotransferase Increased, may become evident only after a product is in use by the general population.

This Alanine Aminotransferase Increased side effect was reported by a consumer or non-health professional from US. A 62-year-old male patient (weight:NA) experienced the following symptoms/conditions: metastatic malignant melanoma.The patient was prescribed Dacarbazine (drug dosage: 1343 Mg, Q3wk), which was initiated on

May 08, 2013. Concurrently used drugs:

Ipilimumab (547 Mg Every 3 Weeks)

Sucrose (Unk)

Betamethasone (Unk)

Fexofenadine Hydrochloride (Unk)

.After starting to take Dacarbazine the consumer reported adverse symptoms, such as: Alanine Aminotransferase Increased, Aspartate Aminotransferase IncreasedThese side effects may potentially be related to Dacarbazine. The patient was hospitalized.

This is a report of a 24-year-old male patient (weight: NA) from US, suffering from the following health symptoms/conditions: hodgkin^s disease nodular sclerosis stage ii, who was treated with Dacarbazine (dosage: NA, start time: NS), combined with:

Adriamycin

Bleomycin

Vinblastine

Bicnu

Etoposide

Cytosine Arabinoside

Melphalan

and developed a serious reaction and side effect(s): Radiation Pneumonitis, Cough, Dyspnoea Exertional, Radiation Fibrosis, Lung Disorder after the beginning of treatment. This case can indicate the possible existence of increased vulnerability to Dacarbazine treatment in male patients, resulting in Radiation Pneumonitis side effect.

Dacarbazine Side Effect Report#9324433 Diffuse Large B-cell Lymphoma

This report suggests a potential DacarbazineDiffuse Large B-cell Lymphoma side effect(s) that can have serious consequences. A 62-year-old female patient (weight: NA) from US was diagnosed with the following symptoms/conditions: hodgkin^s disease and used Dacarbazine (dosage: 6 Cycles) starting NS. After starting Dacarbazine the patient began experiencing various side effects, including: Diffuse Large B-cell LymphomaAdditional drugs used concurrently:

Doxorubicin (6 Cycles)

Doxorubicin

Bleomycin (6 Cycles)

Vinblastine (6 Cycles)

Ifosfamide (2 Cycles)

Carboplatin (6 Cycles)

Etoposide (6 Cycles)

Etoposide (Treatment Of Event)

Although Dacarbazine demonstrated significant improvements in a number of clinically relevant cases, troublesome symptoms, such as Diffuse Large B-cell Lymphoma, may still occur.

This Blood Alkaline Phosphatase Increased problem was reported by a health professional from JP. A 31-year-old male patient (weight: NA) was diagnosed with the following symptoms/conditions: pancreatic neuroendocrine tumour. On

Feb 23, 2012 this consumer started treatment with Dacarbazine (dosage: NA). The following drugs were being taken at the same time:

Epirubicin Hydrochloride

Xeloda

Temodal

Aroglycem (225 Mg)

Sutent (25 Mg)

Amino Acid (1000 Ml)

Sosegon (15 Mg)

Azunol /00517002/

When using Dacarbazine, the patient experienced the following unwanted symptoms/side effects: Blood Alkaline Phosphatase Increased, Gamma-glutamyltransferase Increased, Hepatic Failure, Sepsis, Acute Respiratory Distress Syndrome, Malaise, C-reactive Protein Increased, Paronychia, RashThe patient was hospitalized.Although all drugs are carefully tested before they are licensed for use, they carry side effect risks. Some side effects, such as Blood Alkaline Phosphatase Increased, may become evident only after a product is in use by the general population.

This Vascular Occlusion side effect was reported by a health professional from GB. A 61-year-old male patient (weight:NA) experienced the following symptoms/conditions: hodgkin^s disease stage iv.The patient was prescribed Dacarbazine (drug dosage: Cyclical), which was initiated on NS. Concurrently used drugs:

Vincristine Sulfate (Cyclical)

Doxorubicin Hydrochloride (Cyclical)

Bleomycin

.After starting to take Dacarbazine the consumer reported adverse symptoms, such as: Vascular Occlusion, Vasospasm, Raynaud^s PhenomenonThese side effects may potentially be related to Dacarbazine. The patient was hospitalized.

Dacarbazine Side Effect Report#9121387 Sarcoidosis

This is a report of a 33-year-old female patient (weight: NA) from ES, suffering from the following health symptoms/conditions: hodgkin^s disease, who was treated with Dacarbazine (dosage: NA, start time: NS), combined with:

Adriamycin

Bleomycin

Vinblastine

and developed a serious reaction and side effect(s): Sarcoidosis after the beginning of treatment. This case can indicate the possible existence of increased vulnerability to Dacarbazine treatment in female patients, resulting in Sarcoidosis side effect.

Dacarbazine Side Effect Report#9121317 Bone Marrow Failure

This report suggests a potential DacarbazineBone Marrow Failure side effect(s) that can have serious consequences. A 47-year-old male patient (weight: NA) from FR was diagnosed with the following symptoms/conditions: metastatic malignant melanoma and used Dacarbazine (dosage: NA) starting

Dec 11, 2010. After starting Dacarbazine the patient began experiencing various side effects, including: Bone Marrow FailureAdditional drugs used concurrently:

Vemurafenib

Augmentin

Ciflox

Vancomycin

Tazocilline

Tazocilline

Amiklin

Amiklin

The patient was hospitalized. Although Dacarbazine demonstrated significant improvements in a number of clinically relevant cases, troublesome symptoms, such as Bone Marrow Failure, may still occur.

This Alanine Aminotransferase Increased problem was reported by a consumer or non-health professional from US. A 70-year-old male patient (weight: NA) was diagnosed with the following symptoms/conditions: metastatic malignant melanoma. On

Feb 05, 2013 this consumer started treatment with Dacarbazine (dosage: 1513 Mg (every 3 Weeks)). The following drugs were being taken at the same time:

Mdx-010 (759 Mg (every 3 Weeks))

Amlodipine (Unk)

Olopatadine Hydrochloride (Unk)

Prednisolone (20 Mg Daily)

Prednisolone (15 Mg Daily)

Prednisolone (60 Mg Daily)

Prednisolone (50 Mg Daily)

Prednisolone (60 Mg Daily)

When using Dacarbazine, the patient experienced the following unwanted symptoms/side effects: Alanine Aminotransferase IncreasedThe patient was hospitalized.Although all drugs are carefully tested before they are licensed for use, they carry side effect risks. Some side effects, such as Alanine Aminotransferase Increased, may become evident only after a product is in use by the general population.

This Abdominal Pain side effect was reported by a consumer or non-health professional from US. A female patient (weight:NA) experienced the following symptoms/conditions: NA.The patient was prescribed Dacarbazine (drug dosage: NA), which was initiated on NS. Concurrently used drugs:

Doxorubicin Hydrochloride

Vinblastine Sulfate

.After starting to take Dacarbazine the consumer reported adverse symptoms, such as: Abdominal Pain, Neutropenia, Abdominal Distension, Intestinal Ischaemia, Gastrointestinal NecrosisThese side effects may potentially be related to Dacarbazine. The patient was hospitalized.

Dacarbazine Side Effect Report#9028480 Malignant Fibrous Histiocytoma

This is a report of a 32-year-old male patient (weight: NA) from IN, suffering from the following health symptoms/conditions: hodgkin^s disease recurrent, who was treated with Dacarbazine (dosage: 6 Cycles Of Abvd (dosing Nos), start time: 1994), combined with:

Adriamycin (6 Cycles Of Abvd (dosing Nos))

Bleomycin (6 Cycles Of Abvd (dosing Nos))

Vinblastine (6 Cycles Of Abvd (dosing Nos))

and developed a serious reaction and side effect(s): Malignant Fibrous Histiocytoma after the beginning of treatment. This case can indicate the possible existence of increased vulnerability to Dacarbazine treatment in male patients, resulting in Malignant Fibrous Histiocytoma side effect.

Dacarbazine Side Effect Report#8969157 Acute Lymphocytic Leukaemia

This report suggests a potential DacarbazineAcute Lymphocytic Leukaemia side effect(s) that can have serious consequences. A 51-year-old female patient (weight: NA) from CA was diagnosed with the following symptoms/conditions: hodgkin^s lymphoma and used Dacarbazine (dosage: NA) starting NS. After starting Dacarbazine the patient began experiencing various side effects, including: Acute Lymphocytic LeukaemiaAdditional drugs used concurrently:

Doxorubicin

Bleomycin

Vinblastine

Although Dacarbazine demonstrated significant improvements in a number of clinically relevant cases, troublesome symptoms, such as Acute Lymphocytic Leukaemia, may still occur.

Dacarbazine Side Effect Report#8960715 Respiratory Failure, Hypoxia

This Respiratory Failure problem was reported by a health professional from GB. A 54-year-old male patient (weight: NA) was diagnosed with the following symptoms/conditions: NA. On

May 09, 2012 this consumer started treatment with Dacarbazine (dosage: (not Otherwise Specified)). The following drugs were being taken at the same time:

Vinblastine Sulfate ((not Otherwise Specified))

Doxorubicin Hydrochloride ((not Otherwise Specified))

Bleomycin ((not Otherwise Specified))

Truvada

Darunavir

(ritonavir)

When using Dacarbazine, the patient experienced the following unwanted symptoms/side effects: Respiratory Failure, HypoxiaAlthough all drugs are carefully tested before they are licensed for use, they carry side effect risks. Some side effects, such as Respiratory Failure, may become evident only after a product is in use by the general population.

This Tuberculosis side effect was reported by a physician from IT. A 67-year-old male patient (weight:NA) experienced the following symptoms/conditions: hodgkin^s disease stage iii.The patient was prescribed Dacarbazine (drug dosage: NA), which was initiated on NS. Concurrently used drugs:

Doxorubicin

Bleomycin

Vinblastine

Dexamethasone

Cisplatin

Cytarabine

.After starting to take Dacarbazine the consumer reported adverse symptoms, such as: Tuberculosis, Hodgkin^s Disease Stage IvThese side effects may potentially be related to Dacarbazine.

This is a report of a 66-year-old male patient (weight: NA) from JP, suffering from the following health symptoms/conditions: malignant fibrous histiocytoma, who was treated with Dacarbazine (dosage: NA, start time: NS), combined with:

Pirarubicin

Ifosfamide

Warfarin

and developed a serious reaction and side effect(s): Pleural Effusion, Decreased Appetite after the beginning of treatment. This case can indicate the possible existence of increased vulnerability to Dacarbazine treatment in male patients, resulting in Pleural Effusion side effect.

Dacarbazine Side Effect Report#8793938

This report suggests a potential DacarbazineFoetal Death side effect(s) that can have serious consequences. A 33-year-old female patient (weight: NA) from TR was diagnosed with the following symptoms/conditions: hodgkin^s disease and used Dacarbazine (dosage: NA) starting NS. After starting Dacarbazine the patient began experiencing various side effects, including:Additional drugs used concurrently:

Adriamycin

Vinblastine

Bleomycin

Although Dacarbazine demonstrated significant improvements in a number of clinically relevant cases, troublesome symptoms, such as Foetal Death, may still occur.

This Metastatic Malignant Melanoma problem was reported by a health professional from Brazil. A 74-year-old male patient (weight: NA) was diagnosed with the following symptoms/conditions: NA. On

Apr 24, 2012 this consumer started treatment with Dacarbazine (dosage: NA). The following drugs were being taken at the same time:

Atenolol

Innohep (15000 Iu (15000 Iu, 1 In 1 D), Subcutaneous)

Dexamethasone

Gutalax (sodium Picosulfate)

When using Dacarbazine, the patient experienced the following unwanted symptoms/side effects: Metastatic Malignant Melanoma, Constipation, Neoplasm Progression, Convulsion, Intracranial Pressure Increased, Cerebral HaemorrhageAlthough all drugs are carefully tested before they are licensed for use, they carry side effect risks. Some side effects, such as Metastatic Malignant Melanoma, may become evident only after a product is in use by the general population.

This Glycosylated Haemoglobin Increased side effect was reported by a health professional from Japan. A 67-year-old male patient (weight:NA) experienced the following symptoms/conditions: hodgkin's disease.The patient was prescribed Dacarbazine (drug dosage: 500 Mg), which was initiated on NS. Concurrently used drugs:

This is a report of a 33-year-old male patient (weight: NA) from Israel, suffering from the following health symptoms/conditions: hodgkin's disease, who was treated with Dacarbazine (dosage: 375 Mg/m2, start time: NS), combined with:

Doxorubicin Hcl (25 Mg/m2)

Vinblastine Sulfate (6 G/m2)

Dexamethasone (20mg)

Bleomycin (10 Mg/m2)

and developed a serious reaction and side effect(s): Respiratory Disorder after the beginning of treatment. This case can indicate the possible existence of increased vulnerability to Dacarbazine treatment in male patients, resulting in Respiratory Disorder side effect.

The appearance of Dacarbazine on this list does not mean that FDA has concluded that the drug has the listed risk. It means that FDA has identified a potential safety issue, but it does not mean that FDA has found a causal relationship between the drug and the listed risk.

Search for drug prescribing information: overdose risks, side effects, adverse reactions, and more

What are common Dacarbazine Side Effects for Men?

Track Your Side Effects

Note Your Observations

It is really important to keep track of your health symptoms, right from the time you start a new medicine. You can do it any way you prefer: in a notebook, in a computer file or using our online tool. You should also note down any other medicines you are taking at the same time, because there could be an interaction between these medicines.

Why Your Notes are Important

Your notes could be helpful in several ways:

You can use them to remind you of details that may alert your health care professional(s) to a problem

You will have a record to refer to in the future, in case you are ever prescribed the same medicine again

Log Form

You can use the following log form to write down important information, like the date and time you experienced a side effect and your symptoms, how strong the symptoms were, and any other medicines you were using.

Medicine Name and Dosage:

Side Effects

Scale

Date & Time

Other Medicine(s) or Treatment(s)

Scale: 1 = very mild to 10 = very bad

Side effects reports are analyzed to discover potential health product safety signals. Some important reactions may take an extremely long time to develop or occur infrequently. Continued monitoring of adverse reactions is thus essential to maintain a comprehensive safety and effectiveness profile of health products.

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.

Dacarbazine reports list potential signals of serious risks and new safety information that were identified using the FDA Adverse Event Reporting System (FAERS).
FAERS is a database that contains information on adverse event and medication errors reports submitted to FDA by healthcare professionals (such as physicians, pharmacists, nurses and others), consumers (such as patients, family members, layers and others) and manufacturers.

Notice - The material on this site is for informational purposes only, and is not a substitute for medical advice, diagnosis or treatment provided by a qualified health care provider. Viewing and using of this information is subject to accepting Terms Of Use. PatientsVille.com
does not provide medical advice, diagnosis or treatment. The information regarding adverse reports, reviews and polls contained on PatientsVille.com site has not been scientifically or otherwise verified as to a cause and effect relationship and cannot be
used to estimate the incidence of side effects, adverse drug reactions or for establishing or changing of patient treatments. Thank you for visiting Patientsville.com!